tiprankstipranks

James Kuo Insider Profile

4 Followers
James Kuo, Director at ImmunoPrecise Antibodies, holds 25.50K shares in ImmunoPrecise Antibodies (Ticker: IPA), holds 6.00M shares in Tryp Therapeutics Inc (Ticker: TSE:TRYP). Most recently, James Kuo Bought ― shares of ImmunoPrecise Antibodies on Mar 24, 2023 for an estimated value of 1.62K.
tipranks
James  Kuo

James Kuo
ImmunoPrecise Antibodies (IPA)
Director

Ranked #85,658 out of 98,501 Corporate Insiders

Profitable Transactions

0%
0 out of 3 Profitable Transactions

Average Return

-43.00%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$272K
91.06%
8.94%
A breakdown of James Kuo's holdings

Insider Roles

Tryp Therapeutics Inc
(TRYP)
Chief Executive Officer
ImmunoPrecise Antibodies
(IPA)
Director
Roles that James Kuo holds in companies

Most Profitable Insider Trade

Stock:
ImmunoPrecise Antibodies
(IPA)
Rating:Informative Sell
Date:Aug 25, 2020 - Aug 25, 2021
Return:-14.50%
The most profitable trade made by James Kuo

James Kuo's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
ImmunoPrecise Antibodies
Mar 24, 2023
Director
Informative Buy
1.62K
$32.38K
Tryp Therapeutics Inc
Dec 16, 2020
Chief Executive Officer
Informative Buy
C$330.00K
List of latest transactions for each holding click on a transaction to see James Kuo's performance on stock

James Kuo insider profile FAQ

What is the percentage of profitable transactions made by James Kuo?
The percentage of profitable transactions made by James Kuo is 0%.
    What is the average return per transaction made by James Kuo?
    The average return per transaction made by James Kuo is -43.00%.
      What stocks does James Kuo hold?
      James Kuo holds: IPA, TSE:TRYP stocks.
        What was James Kuo’s latest transaction?
        James Kuo latest transaction was an Informative Buy of $1.62K.
          What was James Kuo's most profitable transaction?
          James Kuo’s most profitable transaction was an Informative Sell of IPA stock on August 25, 2020. The return on the trade was -14.50%.
            What is James Kuo's role in ImmunoPrecise Antibodies?
            James Kuo's role in ImmunoPrecise Antibodies is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.